Autoinflammatory skin disorders in inflammatory bowel diseases, pyoderma gangrenosum and Sweet's syndrome: a comprehensive review and disease classification criteria.
about
Sweet syndrome: long-term follow-up of 138 patients.Pyoderma gangrenosum as a first presentation of inflammatory bowel diseasePeriodic Fever and Neutrophilic Dermatosis: Is It Sweet's Syndrome?Periodic Fever: A Review on Clinical, Management and Guideline for Iranian Patients - Part II.An expanding role for interleukin-1 blockade from gout to cancer.Neutrophilic skin lesions in autoimmune connective tissue diseases: nine cases and a literature review.Association of pyoderma gangrenosum, acne, and suppurative hidradenitis (PASH) shares genetic and cytokine profiles with other autoinflammatory diseases.Paradoxical Autoinflammatory Skin Reaction to Tumor Necrosis Factor Alpha Blockers Manifesting as Amicrobial Pustulosis of the Folds in Patients With Inflammatory Bowel Diseases.Cytokine and Chemokine Profile in Amicrobial Pustulosis of the Folds: Evidence for AutoinflammationAssociated factors and comorbidities in patients with pyoderma gangrenosum in Germany: a retrospective multicentric analysis in 259 patients.Treating inflammation by blocking interleukin-1 in humans.Neutrophilic dermatoses: an update.Pyoderma gangrenosum and systemic lupus erythematosus: a report of five cases and review of the literature.Sweet's syndrome with idiopathic thrombocythemia.A Review and Proposed Approach to the Neutrophilic Dermatoses of Childhood.Neutrophilic dermatoses and autoinflammatory diseases with skin involvement--innate immune disorders.Drug management of neutrophilic dermatoses.Tumor Necrosis Factor-α and IL-17A Activation Induces Pericyte-Mediated Basement Membrane Remodeling in Human Neutrophilic Dermatoses.PAPA, PASH and PAPASH Syndromes: Pathophysiology, Presentation and Treatment.Pyoderma gangrenosum and its syndromic forms: evidence for a link with autoinflammation.SAPHO Syndrome: Current Developments and Approaches to Clinical Treatment.Coexistence of pyoderma gangrenosum and sweet's syndrome in a patient with ulcerative colitisAre neutrophilic dermatoses autoinflammatory disorders?The challenge of treating orphan disease.Cutaneous Manifestations of ANCA-Associated Small Vessels Vasculitis.A Comprehensive Review of Neutrophilic Diseases.Clinical heterogeneity of SAPHO syndrome: challenging diagnose and treatment.Inflammatory Joint Disorders and Neutrophilic Dermatoses: a Comprehensive Review.[Bullous Sweet's syndrome with pulmonary involvement].Labial Pain, Swelling and Fever: An Autoinflammatory Disorder.Sweet's syndrome complicating ulcerative colitis: a rare association.Hidradenitis suppurativa, neutrophilic dermatoses and autoinflammation: what's the link?Keratinocytes and neutrophils are important sources of proinflammatory molecules in hidradenitis suppurativa.Phenotypical characterization of circulating cell subsets in pyoderma gangrenosum patients: the experience of the Italian immuno-pathology group.Therapy of pyoderma gangrenosum in Germany: results of a survey among wound experts.Pyoderma gangrenosum in pregnancy successfully treated with infliximab and prednisone.Postoperative pyoderma gangrenosum in association with renal cell carcinoma and chronic lymphocytic leukemia.Intractable pyoderma gangrenosum in a Crohn's disease patient on vedolizumab.Skin Manifestations of Inflammatory Bowel Disease.The safety of treatments used in pyoderma gangrenosum.
P2860
Q33435554-AA6A9B78-7E71-4E44-B27E-CF7CBFFD2E1FQ34476959-EB21BC26-103F-4EAF-87E0-E9142020B8E6Q34754365-2CF9F716-811B-4EAD-89D3-29D6DBCD04C2Q34772778-7AA19A74-99F3-4B24-9D34-63290E62781EQ35219001-80594DA4-E3A0-4F06-BF5F-4891BEF7F752Q36151831-02BE2F2C-D6FB-46A0-BCB9-AF5F515CF2C3Q36152675-AC02F30D-3519-43BB-91BE-738B81C028D5Q37016608-BC7600D1-95A7-4069-9220-9E05630C1F3FQ37328410-DFF53150-7D76-4448-BBAE-CD2CE0972AC6Q37351858-A734BB1C-42BB-4A3A-A3DF-31D15AA1B779Q37636664-BB3FDEA5-098A-479E-84A1-9113857806E7Q38242975-A42A6191-CA6A-45C5-BD0E-F2E5270AC961Q38246968-32741D89-E9BF-4D69-9FF0-8771F8BC05D5Q38262390-DB1668B3-A47D-45F8-93F3-48AECC6CD61FQ38366349-29AF1DF3-B911-416A-BE2D-04EA1B9BEDC4Q38653628-1D39252E-966D-40A2-943C-B9B4F2753072Q38656412-E2F358E2-DD93-4960-93C6-FE7F7DB44F73Q38727706-AC1777C3-61D5-4C9B-8D2C-0E3EFD191EA4Q38753451-2FA0DB4C-267D-434A-848C-816A2F916EAEQ38815373-587BB044-371C-44FA-916E-EC9FA89218B4Q38815965-0DBB96A2-9AFF-471D-9441-559FF0EAFCA4Q38968619-452793D6-8921-4C16-A520-5E5273C6596CQ39025288-96DD3138-6D8B-4EEC-A69E-71935C7175BFQ39098238-B2ADD299-E21D-4BA1-8F91-2D848AA01470Q39348719-E0ED5C47-4B12-4419-8C80-F99836EF47CAQ39422179-2233AA86-DED5-4978-9615-DEA8E4031BEBQ39446763-299F48AA-2A58-4E14-8C9B-DFB3C0785923Q39452476-98CA95C8-20B9-47F1-8775-8A6006408285Q40064846-637D9E14-EF82-468A-B90B-4B19E967FC95Q40068300-7C6B4D00-B576-4395-878D-3049611CA5E8Q40121922-54C9A03A-32F8-4B4E-A897-F3FC0CD51BABQ40745781-CDF70F65-885E-427A-9720-F9894ED2B9CFQ40966336-234E899B-005E-4996-B0E8-42E7294B8A24Q41158758-2F122AB9-C193-468F-A234-CD72DB1D038FQ41243953-10795AAF-EAD8-4CE4-8773-ED824B234250Q41563416-CE1598CC-DB79-4BD2-8C36-839EA743DB9AQ41892909-2735B664-FE36-4308-B365-84DE148CC530Q42065121-E2BC2A8B-2F3A-4FCE-84A4-A77BF280B279Q44390503-51399640-4C7B-48EA-94B8-F8911C958201Q47641664-DBFD8A53-716D-47EE-8B2B-78A397C8FEC3
P2860
Autoinflammatory skin disorders in inflammatory bowel diseases, pyoderma gangrenosum and Sweet's syndrome: a comprehensive review and disease classification criteria.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Autoinflammatory skin disorder ...... sease classification criteria.
@en
type
label
Autoinflammatory skin disorder ...... sease classification criteria.
@en
prefLabel
Autoinflammatory skin disorder ...... sease classification criteria.
@en
P2093
P2860
P50
P1476
Autoinflammatory skin disorder ...... sease classification criteria.
@en
P2093
Angelo V Marzano
Carlo Crosti
Rim S Ishak
P2860
P2888
P304
P356
10.1007/S12016-012-8351-X
P577
2013-10-01T00:00:00Z
P6179
1023004074